NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: C000000096

Registered date:30/08/2005

Neoadjuvant and adjuvant chemotherapy with ifosfamide and adriamycin for adult high-grade soft tissue sarcomas in the extremities (JCOG0304, Neoadjuvant and adjuvant chemotherapy with IFO/ADM phase II)

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedsoft tissue sarcoma
Date of first enrollment2004/03/01
Target sample size75
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Neoadjuvant and adjuvant chemotherapy

Outcome(s)

Primary Outcomeresponse rate
Secondary Outcome2-year progression free survival, time to progression, overall survival, adverse effect, post-operative morbidity

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum65years-old
GenderMale and Female
Include criteria
Exclude criteria1) Poorly controlled diabetes mellitus 2) poorly controlled hypertension 3) history of myocardial infarction or angina 4) cardiac pacemaker 5) severe urinary dysfunction 6) infectious disease which requires treatment 7) mental disease or mental symptoms which would affect the patient's decision to participate 8) women in pregnant, possibly pregnant or breast feeding 9) active double cancer 10) continuous systemic medication of steroids

Related Information

Contact

public contact
Name Kazuhiro Tanaka, MD, PhD
Address 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, JAPAN Japan
Telephone
E-mail JCOG_sir@ml.jcog.jp
Affiliation JCOG0304 Coordinating Office Department of Orthopaedic Surgery, Kyushu University Hospital
scientific contact
Name Yukihide Iwamoto, MD, PhD
Address 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, JAPAN Japan
Telephone
E-mail
Affiliation Graduate School of Medical Sciences, Kyushu University Department of Orthopaedic Surgery